quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:00·85d
PRRelease
CalciMedica Inc. logo

CalciMedica Announces Discontinuation of Phase 2 KOURAGE Trial in AKI Following Independent Data Monitoring Committee Recommendation

CALC· CalciMedica Inc.
Health Care
Original source

Companies

  • CALC
    CalciMedica Inc.
    Health Care

Recent analyst ratings

  • Jan 29UpdateH.C. Wainwright-

Related

  • INSIDER16d
    SEC Form 4 filed by Bardin Stephen
  • INSIDER16d
    SEC Form 4 filed by Leheny A. Rachel
  • INSIDER16d
    SEC Form 4 filed by Hebbar Sudarshan
  • INSIDER16d
    SEC Form 4 filed by Stauderman Kenneth A.
  • INSIDER16d
    SEC Form 4 filed by Dunn Michael J.
  • INSIDER16d
    SEC Form 4 filed by Roberts Eric W
  • SEC36d
    SEC Form 8-K filed by CalciMedica Inc.
  • SEC43d
    SEC Form EFFECT filed by CalciMedica Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022